Exagen Inc. (XGN)
NASDAQ: XGN
· Real-Time Price · USD
10.78
0.86 (8.67%)
At close: Sep 24, 2025, 3:59 PM
10.96
1.64%
Pre-market: Sep 25, 2025, 08:11 AM EDT
8.67% (1D)
| Bid | 10.06 |
| Market Cap | 237.2M |
| Revenue (ttm) | 58.86M |
| Net Income (ttm) | -16.98M |
| EPS (ttm) | -0.89 |
| PE Ratio (ttm) | -12.11 |
| Forward PE | -29.18 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 11.53 |
| Volume | 368,708 |
| Avg. Volume (20D) | 276,638 |
| Open | 10.09 |
| Previous Close | 9.92 |
| Day's Range | 10.05 - 10.83 |
| 52-Week Range | 2.38 - 10.83 |
| Beta | 1.60 |
| Ex-Dividend Date | n/a |
Analyst Forecast
According to 0 analyst ratings, the average rating for XGN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsExagen Inc. is scheduled to release its earnings on
Nov 11, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
4 months ago
-9.81%
Exagen shares are trading lower after the company ...
Unlock content with
Pro Subscription
